PFE

Pfizer (PFE)

Pfizer Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NYSE:PFE

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/09/26	06:00	Business Wire	Pfizer Voluntarily Withdraws All Lots of Sickle Cell Disease Treatment OXBRYTA® (voxelotor) From Worldwide Markets	NYSE:PFE	Pfizer Inc
2024/09/20	21:11	Business Wire	Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union	NYSE:PFE	Pfizer Inc
2024/09/18	06:01	AllPennyStocks.com	Targeting Cancer's Achilles Heel: AI-Driven DDR Therapies Offer Hope	NYSE:PFE	Pfizer Inc
2024/09/17	23:00	Business Wire	Pfizer Invites Public to View and Listen to Webcast of October 29 Conference Call with Analysts	NYSE:PFE	Pfizer Inc
2024/09/17	02:12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:PFE	Pfizer Inc
2024/09/17	02:11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:PFE	Pfizer Inc
2024/09/17	02:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:PFE	Pfizer Inc
2024/09/17	02:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:PFE	Pfizer Inc
2024/09/17	01:57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:PFE	Pfizer Inc
2024/09/17	01:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:PFE	Pfizer Inc
2024/09/17	01:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:PFE	Pfizer Inc
2024/09/17	01:53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:PFE	Pfizer Inc
2024/09/17	01:52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:PFE	Pfizer Inc
2024/09/17	01:47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:PFE	Pfizer Inc
2024/09/17	01:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:PFE	Pfizer Inc
2024/09/14	21:45	Business Wire	Pfizer Presents Positive Data from Phase 2 Study of Ponsegromab in Patients with Cancer Cachexia	NYSE:PFE	Pfizer Inc
2024/09/14	17:15	Business Wire	Pfizer’s BRAFTOVI® + MEKTOVI® Shows Long-Term Clinically Meaningful Response in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer	NYSE:PFE	Pfizer Inc
2024/09/14	05:49	Edgar (US Regulatory)	Form SC TO-I/A - Tender offer statement by Issuer: [Amend]	NYSE:PFE	Pfizer Inc
2024/09/11	19:45	Business Wire	Pfizer Highlights Diverse Oncology Portfolio and Combination Approaches at ESMO 2024	NYSE:PFE	Pfizer Inc
2024/09/04	07:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:PFE	Pfizer Inc
2024/09/04	07:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:PFE	Pfizer Inc
2024/09/04	07:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:PFE	Pfizer Inc
2024/08/28	23:00	Business Wire	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference	NYSE:PFE	Pfizer Inc
2024/08/27	19:45	Business Wire	Pfizer Launches PfizerForAll™, a Digital Platform that Helps Simplify Access to Healthcare	NYSE:PFE	Pfizer Inc
2024/08/23	21:20	IH Market News	Cruise and Uber Join Forces for Robotaxis, Alibaba Shifts Primary Listing to Hong Kong, Altria Hikes Dividend 4.1%	NYSE:PFE	Pfizer Inc
2024/08/23	03:15	Business Wire	Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine	NYSE:PFE	Pfizer Inc
2024/08/23	00:17	Edgar (US Regulatory)	Form SC TO-I/A - Tender offer statement by Issuer: [Amend]	NYSE:PFE	Pfizer Inc
2024/08/17	04:19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:PFE	Pfizer Inc
2024/08/17	04:19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:PFE	Pfizer Inc
2024/08/16	19:45	Business Wire	Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and COVID-19 in Individuals 18-64 Years of Age	NYSE:PFE	Pfizer Inc